Ropivacaine 0.5% administered via a femoral catheter: is the obturator nerve also blocked?
To the Editor: Weber et al. 1 sought to determine the optimal dose of ropivacaine 0.5% for analgesia injected through a femoral catheter, and as a secondary endpoint the success rate of obturator nerve block. The authors found a very high rate of effective block of the obturator nerve (up to 95%). This is in contrast with the results found by Parkinson et al. 2 We have some concerns regarding the observations of Weber et al. 1 due to the limitations of their study design. First, threading a femoral catheter up to 12 cm is hazardous. Capdevila et al. 3 demonstrated that threading the catheter 16 to 20 cm results in a correct placement close to the lumbar plexus in only 23% of the patients, emphasizing that the course of the catheter was unpredictable. Ritter 4 was unable to demonstrate in cadavers, a femoral nerve sheath capable of conveying a solution -or a catheter -from the inguinal ligament to the lumbar plexus. Unfortunately, Weber et al. 1 did not verify radiologically the position of the catheter tip, leaving some doubt regarding its position.
Bouaziz et al. 5 demonstrated that sensory tests (cold and light touch perception) -as used in Weber's study -are inadequate to assess obturator nerve block. After performing a selective obturator nerve block, supported by a marked decrease of adductor strength, the authors showed an absence of sensory cutaneous contribution in 57% of patients. Without electromyogram monitoring or adductor strength assessment, blockade of the obturator nerve is only speculative. In the model used by the authors, sensory assessment of the medial side of the knee is even more complex, since the sciatic nerve may also have sensory branches in this area. Weber et al. 1 found that 20 mL ropivacaine 0.5% was the most appropriate dose to block the femoral nerve. On the other hand, evidence of obturator nerve block is speculative, and the design of their study does not fully support this conclusion. We view that there is sufficient evidence in the current literature to doubt the existence of the three-in-one block. 
Delayed respiratory depression after interscalene blockade for shoulder surgery in geriatric patients
To the Editor: In our institution, as in many others, surgery on the proximal part of upper arm is usually performed under interscalene brachial plexus block (ISB) with general anesthesia (GA) upon request of the surgeon. We recently experienced three cases of delayed respiratory distress after complete recovery of uneventful anesthesia in geriatric patients who received ISB and GA for surgeries on the upper arm or shoulder. In all cases ISB was performed using a nerve stimulator at first attempt by the Winnie approach.
In the first case, a 74-yr-old female received ISB with a 30 mL mixture containing ropivacaine 112 mg and lidocaine 150 mg with epinephrine, injected slowly in divided doses. Ten minutes later, GA was administered with sufentanil, propofol, sevoflurane and atracurium to facilitate tracheal intubation. At completion
